Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Two weeks to go. If no liquidity events are announced by the 12/21 call, Ken’s credibility takes a big hit to me. I’ve been saying this for months as he teased gleefully on past podcasts that one if not two events were coming in 2022. Also if you go back to listen to the past podcast he mentioned updates that never happen. We shall see but I am not optimistic he will announce much of anything by year end. I hope I’m wrong but this has been the pattern for the two years I have been long this stock. Ken talks a big game but delivers very little. The only thing that matters to me are liquidity events. Why? Because that is the end result of their core business model, their Tech Incubator business. Tic Tok Tic Tok.
Let’s just kick that old can down the road. My prediction is that do not close any liquidity events this year as advertised, and that Ken is trying to buy enough time to manufacture the excuses for not getting these done. Tic toc Tic toc on hearing the nonsense excuses.
Time to put up or shut up. Months ago Ken intimated they were close to completing the liquidity events for MJLink and Huntpost. Tic toc Tik toc. If he does not announce a liquidity event before the end of the year, Ken will lose credibility. No more excuses nor kicking the can down the road.
By my math they should have completed the IND. Time to show up CUBT management
If that was true this news would have to be disclosed given his position with the company. I have not seen an 8k to this effect.
The name change will occur long before the uplist based on Ken’s promise not to uplist prior to a $.05 price. It will take some time to get there imo. My interpretation is that Ken is expecting and planning to get the name change and complete the liquidity event at or near the same time. Thanks for the definition of the term in conjunction with. Maybe tell Ken since it was his comment. Good luck .
At 11:26 mark into the podcast Ken said “As soon as the name change happens we can then move forward in conjunction with with the liquidity events so that we can do that uplisting.” It does seem like Ken intimates here the name change will occur prior tor the liquidity event.
This makes it sounds like the name change has at least some bearing on the liquidity events. Either way both will likely occur in the next two weeks.
Totally agree. This was the first step. Let’s see the news that follows. Hopefully just as you laid out.
$512K in Revs. vs $140K Q2. Sequential revenue growth of 265%.
Fully expected Q3 ER out by now based on Ken’s comments in his last podcast. Ken needs to stop over promising and under delivering on his expectations around his comments on deliverables. This has been the fundamental reason I question his credibility. I hope Ken reads the comments here and actually takes the criticism to heart. And how close are we now to end of year where he said he expected two, not one, liquidity events by end of year? If he delivers on those I will give him full credit. But I am very skeptical he makes these at this point. All my opinion after being long this stock for two years now.
They have less than 60 days to do a liquidity event. If they do not I will question management. Ken and Todd have said all year they were targeting one if not two liquidity events by year end, talking specifics like MJ Link being acquired and HuntPost going way of SPAC. If they do not accomplish this their credibility will take a major hit. No more kicking the can down the road. Been doing that for a long time.
They also are not required to make the comment in their filing. My conclusion is that it ain’t over and I am drawing that conclusion based, in part, on the comment. Whether you or anyone else agrees with my conclusion, I care not.
It is straightforward. It is what I meant. I expect another offering shortly.
You been saying this a long time. Not going to happen.
“The Company also requests in accordance with Rule 457(p) of the Act that all fees paid to the Commission in connection with the filing of the Registration Statement be credited for future use.” This comment in the RW today lends credence to your assumption that it ain’t over. I don’t think they have come this far to not get it done. Negotiations take time, particularly given this is an OTC Pink sheet company trying to get to a major exchange.
Under Rule 457(p), the filing fees from unsold securities may be carried over to offset filing fees for a subsequent offering. I don’t think they would make this comment if they were throwing in the towel.
It ain’t over. Far from it. It will happen. Mark my words.
Until we actually hear from the company everything is speculation. I think they will still get this done. Securing financing is rarely easy, especially when moving from the pinks to a real exchange. Totally understand the frustrations here. Got a few myself. But I do think they will get this done. Lots going on behind the scenes we simply do not know.
They will get this done. Believe the noise if you choose.
You can lead em to water but the horse is going to believe what they want. Insiders are not selling shares nor will they after the uplist which I expect within a week of not sooner.
You won’t be calling it OTC much longer. And no more “stinky pinky” tag. You’ll have to come up with some other cute little saying. LOL.
Current market cap is just $10.86M. That is the only number I care about. I think the upside is significant.
Market makers holding this back. Welcome to the world of manipulation. I am getting some good buys.
Got filled at .0197
Interesting. I’m in the hunt too. Love these 1 share sells sub .02. Someone needs to clear the decks.
Yep. It’s happening.
Give it a rest boys. Let’s just see what happens.
The big question will be what the stock price will be after a liquidity event. And if it is less than $.05 will Ken stick to his commitment on not doing the RS and uplist below a $.05 price.
I was encouraged by the latest podcast. Glad they said they would not add the 2B shares that were authorized. That tells me they expect to have funds without further dilution prior to any uplist. I liked hearing that, the revenue growth and his confidence in the two liquidity through acquisition (MJ Link) and SPAC (for Huntpost).
Also looking forward to hearing their investor presentations around October 11. That will be good assuming they will be in a quiet period until the Q3 ER is released, which I also liked hearing may be end of October.
They are estimating the proceeds at $7.8MM.
They have estimated the use of proceeds among the various solutions.
It is pretty clear the number one priority of the use of funds will be around Metformin and AMD.
They clearly state below $3.0MM for Metformin/AMD. Even if they spend $2.4MM on G&A, this will give them plenty of runway to monetize Metformin. And of course all forecasted expenses are “estimates” until they are actually made, including the $200k per month G&A.
Retinal Degeneration
We estimate that it will cost approximately $2.0 million in pre-clinical, IND-enabling studies, manufacturing, and other costs related to submitting an IND application. Provided we are able to receive IND approval, we estimate that it will cost approximately an additional $1.0 million to conduct and complete a phase 1 clinical trial of dry age-related macular degeneration (AMD) and Geographic Atrophy. Pursuant to the CRADA (see section of this Prospectus entitled “Product Development” – Degenerative Eye Diseases” for more information), our contribution to the first clinical trial will be a maximum of $115,000, with the balance to be covered by the National Eye Institute.
I looked at many posts (I would consider that looking a little harder as you suggested). Your post yesterday is the only one I saw about no warrants. I find the timing of your comment yesterday interesting considering the new S1 came out today without mention of warrants.
Your links took me to a blank page in iHub. I’ll take your word for it. Thanks for the links. Hope the warrants stay out of the mix.
How could no warrants not be a positive? Less dilution, correct?
I see no posts along that line. The S1 today is different from the one earlier in the month.
The new prospectus makes no mention of warrants either, just 1,553,398 shares of common stock. Unless I am reading this wrong, seems the terms are different.
You wanted it at .0088 and you got it. I will be buying right along with you.
Many here will be singing a different tune in 30 days once the dust settles and we actually know the terms of the deal, and some news gets released right after provoking fear to drive sellers to a price they will then gobble up. I’m a buyer. A big buyer down here.
Probably be 1M after the uplist to AMEX. Any good news, and there will be much imo, will send this thing flying.
My hunch is you are wrong. I think they get the S1 done.
I have asked the question, multiple times. And for me I am not as interested in the pre-split RS ratio but rather on the market cap which is about $15M. I personally cannot change the price of the stock nor can the IR guy. I personally feel the upside value is high compared to the current market cap. That’s why I am here. I can piss and moan all day long and make posts that make me feel intellectually superior but at the end of the day nothing you or I can do will change anything. That is the difference between you and me. I realize that you and you don’t. If you feel so bad about the company why do you still own 2M shares (seems you been selling some shares since the last time you reported 3M).
Let me be clear. Those words make me feel powerful. You will be proven wrong. And I will be looking for the “I was wrong” post when it happens.
Good points! It would be nice to see that MJ Link acquisition.